Woman reading about the 340B Program

Healthy Outcomes: Navigating the 340B Drug Pricing Program for healthcare providers 

A conversation with Sherri Faber, president and CEO of 340B Compliance Partners

On this episode of Healthy Outcomes, our host Mark Ross interviews Sherri Faber, president and CEO of 340B Compliance Partners. Together, they discuss the 340B Drug Pricing Program (340B Program), a federal government program created in 1992 that requires pharmaceutical manufacturers to provide outpatient pharmaceuticals to eligible healthcare providers and covered entities at discounted prices.  

Topics of discussion include:  

  • History of the 340B Program   
  • Financial benefits for eligible healthcare providers participating in the 340B Program, specifically through cost savings and contract pharmacy arrangements   
  • Compliance requirements to participate in the 340B Program  
  • Regulatory oversight and monitoring of the 340B Program  
  • Strategies adopted by healthcare providers related to the 340B Program 
  • Future outlook of the 340B Program 

  Connect with us to hear more about our healthcare team.  

Sherri Faber, RPh, MHA 

Sherri Faber is the president and CEO of 340B Compliance Partners and has nearly 30 years of experience in the healthcare industry. Prior to her current role, Sherri served as a director of pharmacy for more than a decade and is an Apexus 340B advanced operations certified expert, serving as a past speaker on 340B audits at a multi-state pharmacy conference. 

Listen or subscribe to Healthy Outcomes on your favorite platform.

  1. Listen on Apple Podcasts
  2. Listen on Google Podcasts
  3. Listen on iHeartRadio
  4. Listen on Spotify
  5. Listen on Stitcher
Mark Ross
construction worker at building site
Next up

BuzzHouse: The dangers of using toxic building materials in developments